Category Archives: Cancer Treatment

Breast cancer cells’ sugar craving is target for new type of treatment

The treatment exploits a novel link, identified by the scientists, between sugar processing in the cells and their growth and division. This approach to treating breast cancer offers a real alternative to chemotherapy as it targets the active cancer cells and not normal cells, reducing the risk of side effects that affect thousands of women undergoing treatment. Breast Cancer Campaign funded scientist, Dr Jeremy Blaydes at the University of Southampton, has shown for the first time that chemicals called cyclic peptide inhibitors can stop ‘sweet toothed’ cancer cells from growing and multiplying by blocking proteins in the cells called CtBPs (C-terminal binding proteins). …

New protein discovered with vast potential for treatment of cancer and other diseases

The identification of CPTP was the result of an international collaboration that built on prior research by co-lead author Charles Chalfant, Ph.D., Endowed Chair of Cancer Cell Signaling and member of the Cancer Cell Signaling program at Virginia Commonwealth University Massey Cancer Center as well as professor in the Department of Biochemistry and Molecular Biology at VCU School of Medicine. The team discovered that CPTP regulates levels of biologically active lipids, which are molecules such as fatty acids that often play a role in cell signaling…

Ancient viruses that function in early human development may play role in cancer

"Understanding this previously ignored part of the human genome, its role in human development, and how it may be taken over by disease, opens a new frontier in science with important implications for medical advances," said Philipp Kapranov, Ph.D., lead researcher at the St. …

Oxygen – key to most life – decelerates many cancer tumors when combined with radiation therapy

In research examining tissue oxygenation levels and predicting radiation response, UT Southwestern scientists led by Dr. Ralph Mason reported in the June 27 online issue of Magnetic Resonance in Medicine that countering hypoxic and aggressive tumors with an "oxygen challenge" — inhaling oxygen while monitoring tumor response — coincides with a greater delay in tumor growth in an irradiated animal model…

Drug research: New technique shows if drugs have reached intended target

Named the "Cellular Thermal Shift Assay" (CETSA), scientists can now know for sure if a drug had reached its target protein in the body, which is a critical step in determining the effectiveness of most medicines. Presently, scientists can only hypothesise if a drug has indeed reached its target protein, leading to expensive and prolonged drug development process. …

Thwarting protein production slows cancer cells’ malignant march

From yeast to worms to humans, this stress response and its primary regulator, heat shock factor 1 (HSF1), help normal cells adapt to harsh environments, including the presence of heavy metals, high salt concentrations, low oxygen levels, and of course increased temperatures. "In a perverted twist of fate, cancer cells take advantage of this incredibly ancient survival strategy — the heat shock response — to help them survive despite the best efforts of our own natural defenses, and sophisticated therapeutics, to kill them," says Whitehead Member Susan Lindquist. "And trumping all that, we find it not only helps them survive, it helps them thrive!" Across tumor and cancer types, cancer cells rely on the heat shock response and HSF1 to support the production of vast quantities of proteins and the high-energy demands needed to propel malignancy…

Missing piece of pediatric cancer puzzle found

In a study published in the July issue of the Proceedings of the National Academy of Sciences, researchers found a missing piece of the pediatric cancer puzzle. Changxian Shen, PhD, senior research associate at the Center for Childhood Cancer and Blood Diseases at The Research Institute at Nationwide Children’s Hospital, and Peter Houghton, PhD, director of the center, may have identified one mechanism behind the early development of some pediatric solid tumors — as well as a target for future pediatric cancer therapies…